Clopidogrel increases risk of MACE in patients with CYP2C19 LoF alleles

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2025年 / 2047卷 / 1期
关键词：
D O I：
10.1007/s40278-025-77792-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [41] The effect of CYP2C19 and CYP2C9 polymorphism on the pharmacodynamics of clopidogrel
    Jiang, Juanjuan
    Tian, Lei
    Han, Lulu
    Yan, Yan
    Huang, Yiling
    Liu, Hong
    Xie, Shuang
    Li, Yishi
    CARDIOLOGY, 2011, 120 : 30 - 31
  • [42] Two single-tube assays to detect the CYP2C19*2 and CYP2C19*3 alleles.
    Hersberger, M
    Marti-Jaun, J
    Rentsch, K
    Hänseler, E
    CLINICAL CHEMISTRY, 2001, 47 (06) : A66 - A66
  • [43] Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia
    Minderhoud, Crista
    Otten, Leila S.
    Hilkens, Pieter H. E.
    van den Broek, Marcel P. H.
    Harmsze, Ankie M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3335 - 3340
  • [44] Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention
    Ziwei Xi
    Yujie Zhou
    Yingxin Zhao
    Xiaoli Liu
    Jing Liang
    Meng Chai
    Ying Yu
    Wei Liu
    Cardiovascular Drugs and Therapy, 2020, 34 : 179 - 188
  • [45] Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention
    Xi, Ziwei
    Zhou, Yujie
    Zhao, Yingxin
    Liu, Xiaoli
    Liang, Jing
    Chai, Meng
    Yu, Ying
    Liu, Wei
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 179 - 188
  • [46] Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
    Pare, Guillaume
    Mehta, Shamir R.
    Yusuf, Salim
    Anand, Sonia S.
    Connolly, Stuart J.
    Hirsh, Jack
    Simonsen, Katy
    Bhatt, Deepak L.
    Fox, Keith A. A.
    Eikelboom, John W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18): : 1704 - 1714
  • [47] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment REPLY
    Pare, Guillaume
    Mehta, Shamir R.
    Eikelboom, John W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 482 - 482
  • [48] Does CYP2C19 inhibition lead to clopidogrel thrombogenicity?
    Cohen, M. J.
    MEDICAL HYPOTHESES, 2011, 77 (03) : 448 - 450
  • [49] The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19☆35 and CYP2C19☆2 Alleles
    Chaudhry, Amarjit S.
    Prasad, Bhagwat
    Shirasaka, Yoshiyuki
    Fohner, Alison
    Finkelstein, David
    Fan, Yiping
    Wang, Shuoguo
    Wu, Gang
    Aklillu, Eleni
    Sim, Sarah C.
    Thummel, Kenneth E.
    Schuetz, Erin G.
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (08) : 1226 - 1235
  • [50] Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy
    Tantray, Javeed Ahmad
    Reddy, K. Pratap
    Jamil, Kaiser
    Kumar, Y. Shiva
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 229 : 113 - 118
12345